1-5 of 5
Antonietta Ferretti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Clinical Trials & Observations
Francesca Palandri, Elena Rossi, Daniela Bartoletti, Antonietta Ferretti, Marco Ruggeri, Elisa Lucchini, Valentina Carrai, Wilma Barcellini, Andrea Patriarca, Elena Rivolti, Ugo Consoli, Silvia Cantoni, Esther Natalie Oliva, Federico Chiurazzi, Giovanni Caocci, Gaetano Giuffrida, Alessandra Borchiellini, Giuseppe Auteri, Erminia Baldacci, Giuseppe Carli, Daniela Nicolosi, Emanuele Sutto, Monica Carpenedo, Michele Cavo, Maria Gabriella Mazzucconi, Francesco Zaja, Valerio De Stefano, Francesco Rodeghiero, Nicola Vianelli
Journal: Blood
Blood (2021) 138 (7): 571–583.
https://doi.org/10.1182/blood.2021010735
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort

Sofia Chiatamone Ricci, MD, Maria Antonietta Arleo, MD, Stefania Trasarti, MD, Cristina Santoro, MD PhD, Massimo Breccia, MD, Luisa Bizzoni, MD, Ida Carmosino, Marco Mancini, Erminia Baldacci, MD, Matteo Molica, MD, Daniela De Benedittis, MD, Giulia Ciotti, MD, Elena Mariggiò, MD, Sara Mohamed, MD, Maria Lucia De Luca, MD, Giacinta Pistilli, MD, Annalisa Mancuso, MD, Chiara Lisi, MD, Daniela Diverio, Marco Vignetti, MD, Robin Foà, MD, Roberto Latagliata, Antonietta Ferretti, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5464.
https://doi.org/10.1182/blood-2018-99-117905
Published: 2018
Journal Articles

Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study

Francesca Romana Mauro, MD PhD, Francesco Zaja, Stefano Molica, MD, Marta Coscia, MD PhD, Anna Marina Liberati, Alfonso Piciocchi, Fiorella Ilariucci, MD, Filomena Russo, MD, Francesca Re, MD, Alessandra Tedeschi, MD, Anna Baraldi, MD, Angelo Michele Carella, Alessandro Gozzetti, MD, Giovanni Del Poeta, Pr, MD, Agostino Cortelezzi, MD, Roberta Battistini, MD, Emilia Iannella, MD, Antonietta Ferretti, MD, Ilaria Del Giudice, MD PhD, Irene Della Starza, PhD, Sara Raponi, PhD, Maria Stefania De Propris, PhD, Caterina Ilari, PhD, Luciana Cafforio, PhD, Mauro Nanni, PhD, Paola Fazi, Marco Vignetti, Antonino Neri, Pr, MD, Giorgina Specchia, Pr, MD, Antonio Cuneo, Pr, MD, Anna Guarini, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 2946.
https://doi.org/10.1182/blood.V126.23.2946.2946
Published: 2015
Journal Articles

Clinical Features of Idiopathic Erythrocytosis Compared to Polycythemia Vera JAK-2 V617F Positive and Negative Patients

Roberto Latagliata, Agostino Tafuri, Antonio Spadea, Antonietta Ferretti, Daniela Diverio, Massimo Breccia, Mariella D'Andrea, Alessandro Andriani, Marco Montanaro, Michele Cedrone, Enrico Montefusco, Angela Rago, M.D., Odoardo Maria Olimpieri, Antonino Bagnato, MD, Francesca Biondo, Federico Vozella, Maria Cantonetti, MD, Maria Concetta Petti, MD, Giuliana Alimena
Journal: Blood
Blood (2011) 118 (21): 5172.
https://doi.org/10.1182/blood.V118.21.5172.5172
Published: 2011
Journal Articles

Complete Cytogenetic Response After 3 Months Is a Very Early Indicator of Good Response to Imatinib As Front-Line Treatment in Chronic Myelogenous Leukemia,

Roberto Latagliata, Massimo Breccia, Ida Carmosino, Federico Vozella, Paola Volpicelli, Antonietta Ferretti, Giuseppina Loglisci, MD, Michelina Santopietro, Vincenzo Federico, Rosa De Cuia, Daniela Diverio, Mauro Nanni, PhD, Marco Mancini, Giuliana Alimena
Journal: Blood
Blood (2011) 118 (21): 3783.
https://doi.org/10.1182/blood.V118.21.3783.3783
Published: 2011